Ogasawara Takeshi, Shida Takashi, Nomura Satoru, Takahara Yoshihiro, Uno Hidehiko, Takahashi Makoto, Komatsu Teisuke
Dept. of Hepato-Gastrointestinal Surgery, Funabashi Central Hospital.
Gan To Kagaku Ryoho. 2015 Nov;42(12):1959-61.
A 71-year-old man was diagnosed with a gastric tumor approximately 50mm in diameter on computed tomography (CT). In January 2000, he underwent a proximal gastrectomy. Pathological examination showed 5 mitoses per 50 high-power fields, while immunohistochemical analysis showed positive staining for KIT. Accordingly, the tumor was diagnosed as an intermediate- risk malignant gastrointestinal stromal tumor (GIST) for which the patient was followed. In January 2002, an abdominal CT scan revealed multiple hepatic tumors and a lower abdominal tumor, and the patient was diagnosed with liver metastases and peritoneal disseminations from GIST. After informed consent was provided, chemotherapy with 400 mg/day imatinib was initiated. The patient demonstrated a partial response 2 months after treatment. At 12 years 8 months after the diagnosis of liver metastasis and peritoneal disseminations, the patient shows no sign of recurrence.
一名71岁男性经计算机断层扫描(CT)诊断为直径约50mm的胃肿瘤。2000年1月,他接受了近端胃切除术。病理检查显示每50个高倍视野中有5个有丝分裂,而免疫组化分析显示KIT染色呈阳性。因此,该肿瘤被诊断为中度风险的恶性胃肠道间质瘤(GIST),对该患者进行了随访。2002年1月,腹部CT扫描显示多个肝肿瘤和下腹部肿瘤,该患者被诊断为GIST肝转移和腹膜播散。在获得知情同意后,开始使用伊马替尼400mg/天进行化疗。治疗2个月后患者显示部分缓解。在诊断为肝转移和腹膜播散12年8个月后,患者无复发迹象。